News Headlines Article

Multiple Sclerosis Drug Doesn’t Prevent Onset of Disability, Study Finds
New York Times

The most widely prescribed drug for treating multiple sclerosis has little or no effect on a patient’s progression to disability, a new study has found.

The medicine, interferon beta, does help reduce the development of brain lesions and limit the frequency of relapses, but until now there have been few well-controlled long-term studies demonstrating its effectiveness at preventing the onset of irreversible disability.

Commands